Events

Rappel de AMPLICOR HPV Amplification

Selon L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), ce/cet/cette rappel concerne un dispositif en/au/aux/à France qui a été fabriqué par Roche Diagnostics.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • Date
    2005-04-11
  • Pays de l'événement
    France
  • Source de l'événement
    ANSM
  • URL de la source de l'événement
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-d-un-lot-du-dmdiv-kit-amplicor-hpv-amplification-roche-diagnostics
  • Notes / Alertes
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Notes supplémentaires dans les données
  • Action
    On April 6, 2005, the company ROCHE Diagnostics withdrew from the market lot F09579 of the medical device for in vitro diagnostic called Kit AMPLICOR HPV Amplification reference 3610799190 following. the possibility of obtaining more frequent ß-globin Optical Density results for the positive control, leading to the invalidation of the series. the theoretical possibility that a sample with a very low HPV titre may give a negative result even though the series has been validated by the positive control. This device is used for the detection of high-risk human papillomavirus (HPV) DNA genotypes in clinical specimens (cervical cells taken in liquid medium). The company has directly notified the recipients of the offending lot by means of the message. attached (06/04/2005) (78 ko) validated by the Afssaps .. The competent European authorities concerned are informed directly by the manufacturer. This information is intended for laboratory managers, the directors of health and to the correspondents of reactovigilance for diffusion, if necessary, to the services concerned.

Device

AMPLICOR HPV Amplification
  • Modèle / numéro de série
  • Description du dispositif
    in-vitro_medical_device
  • Manufacturer
    Roche Diagnostics

Manufacturer

Roche Diagnostics